Merrill Pauline T

2 articles in GJC

The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema.

Merrill Pauline T, Holekamp Nancy, Roth Daniel, Kasper Jonathan, Grigorian Ruben

Am J OphthalmolOct 20229 citationsObservational Study

The FAc implant significantly reduced treatment burden and improved vision in DME patients over 36 months, offering better disease control with fewer injections.

Full abstract PubMed

Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.

Merrill Pauline T, Clark W Lloyd, Banker Alay S, Fardeau Christine, Franco Pablo, LeHoang Phuc et al.

OphthalmologyApr 202029 citationsRandomized Controlled Trial

Intravitreal sirolimus (440 μg) effectively reduced inflammation in noninfectious posterior uveitis with good safety and minimal IOP impact, offering a new treatment option.

Full abstract PubMed

All 2 articles loaded

Global Search

Merrill Pauline T

The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema.

Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.